These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18405015)

  • 1. Enterococcal infection.
    Gould D
    Nurs Stand; 2008 Mar 12-18; 22(27):40-3. PubMed ID: 18405015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of vancomycin-resistant enterococci (VRE) in a hematological oncology ward and hygienic preventive measures. A long-term study.
    Knoll M; Daeschlein G; Okpara-Hofmann J; Klare I; Wilhelms D; Wolf HH; Borneff-Lipp M
    Onkologie; 2005 Apr; 28(4):187-92. PubMed ID: 15840966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.
    Pereira GH; Müller PR; Zanella RC; de Jesus Castro Lima M; Torchio DS; Levin AS
    Am J Infect Control; 2010 Jun; 38(5):406-9. PubMed ID: 20006408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
    Ott M; Wirick H
    Can Oper Room Nurs J; 2008 Mar; 26(1):21-4, 26-9, 32. PubMed ID: 18444472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
    Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
    J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of an outbreak of vancomycin-resistant enterococci in several hospitals of western Switzerland].
    Senn L; Petignant C; Chabanel D; Zanetti G
    Rev Med Suisse; 2013 Apr; 9(383):890-3. PubMed ID: 23697084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterococci.
    Chadwick PR; Chadwick CD; Oppenheim BA
    J Hosp Infect; 1996 Jun; 33(2):83-92. PubMed ID: 8808742
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening patients for glycopeptide-resistant enterococci.
    Chadwick PR; Elliot J; Rowland P; Keaney MG; Joseph LA
    J Hosp Infect; 1996 Jul; 33(3):226-8. PubMed ID: 8827510
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit.
    Ozorowski T; Kawalec M; Zaleska M; Konopka L; Hryniewicz W
    Pol Arch Med Wewn; 2009 Nov; 119(11):712-8. PubMed ID: 19920795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.
    ;
    Can Commun Dis Rep; 1997 Dec; 23 Suppl 8():i-iv, 1-16, i-iv, 1-19. PubMed ID: 11195274
    [No Abstract]   [Full Text] [Related]  

  • 12. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to approach management of an outbreak caused by enterococci].
    Pasquarella C
    Ann Ig; 2000; 12(4 Suppl 2):115-21. PubMed ID: 11100561
    [No Abstract]   [Full Text] [Related]  

  • 14. Vancomycin-resistant enterococci in health care facilities.
    Roger M; St-Antoine P; Coutlée F
    N Engl J Med; 2001 Sep; 345(10):768-9. PubMed ID: 11547753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of vancomycin-resistant enterococcus in health care facilities in a region.
    Ostrowsky BE; Trick WE; Sohn AH; Quirk SB; Holt S; Carson LA; Hill BC; Arduino MJ; Kuehnert MJ; Jarvis WR
    N Engl J Med; 2001 May; 344(19):1427-33. PubMed ID: 11346807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing vancomycin-resistant enterococci. A winning team approach.
    Robinson K; Duff Z; Mercer J; Cran M; Gill-Morton P; Main S
    Can Nurse; 1997 Nov; 93(10):36-9. PubMed ID: 9444145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterococcal resistance--an overview.
    Marothi YA; Agnihotri H; Dubey D
    Indian J Med Microbiol; 2005 Oct; 23(4):214-9. PubMed ID: 16327115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment.
    Sample ML; Gravel D; Oxley C; Toye B; Garber G; Ramotar K
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):468-70. PubMed ID: 12186215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.